economic evaluations

A new missing data model in trial-based CEAs
Hello folks and happy new year! Despite all the problems that occurred in this period in relation to the pandemic and travel restrictions, I hope you had a nice break and recharged your batteries for the upcoming months.
Last updated on Jan 5, 2022 discussion, missing data, academia
A new missing data model in trial-based CEAs
Baseline adjustment in trial based CEA
Recently I have come across something I found a little odd when performing a statistical analysis of trial-based CEA data and I would like to share here my experience in the hope that anybody may be able to read it (and correct me if I am wrong).
Last updated on Oct 10, 2021 discussion
Baseline adjustment in trial based CEA
Handling missing values in individual-level cost-effectiveness analyses
Invited presentation
Jun 22, 2021
Project
missingHE a Package to Handle Missing Data in Health Economic Evaluations
Invited presentation
Jun 1, 2021
Project
Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations
Objectives: In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that …
PDF Cite Project Slides
Linear mixed models to handle missing at random data in trial-based economic evaluations
Contributed presentation
Jan 6, 2021
Project
A Bayesian framework for patient-level partitioned survival cost-utility analysis
Patient-level health economic data collected alongside clinical trials are an important component of the process of technology …
PDF Project Slides
Understanding Health Economics in Clinical Trials
Three day short course"
Nov 9, 2020
Project Slides
Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations
Health economic evaluations based on patient-level data collected alongside clinical trials (e.g. health related quality of life and …
PDF Project Slides
Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness
Results from randomised trials show adding abiraterone acetate plus prednisolone (AAP) to standard of care (SOC) improves disease-free …
PDF Project Slides